Closed sbello closed 7 months ago
Will do. I will work to get them into the February release.
Taking a look at this now.
It looks like LQT8 (DOID:0110649) and Timothy syndrome (DOID:0060173) were both in the DO previously and merged because they were given the same name (#267). LQT8/DOID:0110649 was added shortly before the merger (in 53e742431b056ab40421ead756ab81f48cb084b0 on Feb 13 2017), while Timothy syndrome/DOID:0060173 pre-dates the DO's move to git/GitHub.
Although in some of these CACNA1C variants, TS-related extra-cardiac phenotype was not always found, only with QT prolongation and arrhythmia, thus described as non-TS LQT8 (Ref. 16).
Interestingly, depending on the gain- or loss-of-function nature of the variation, this gene has been associated with other syndromes like nonsyndromic long QT syndrome 8, short QT, and Brugada syndrome.
Timothy syndrome (TS) was initially identified in the early 1990s as a severe form of long-QT syndrome, comorbid with syndactyly(63, 64, 65). This rare clinical disorder would eventually be the first documented CaV1.2 channelopathy, and has been designated as long QT type 8 (LQT8).
So it seems invocation of LQT8 in the literature has been used as a grouping term (as it is in Orphanet) and as a non-syndromic variant of long QT.
The literature seems clear in defining 'Neurodevelopmental disorder with hypotonia, language delay, and skeletal defects with or without seizures' as separate from Timothy syndrome but I'm wondering how to handle the phenotypic variability.
OMIM has defined this disease based on the patients with missense mutations as described by https://pubmed.ncbi.nlm.nih.gov/34163037/, but there is another set of patients with truncating mutations with a fairly discernable phenotype that OMIM has included with the comment:
Individuals with truncating variants in the CACNA1C gene have also been described
I favor creating two diseases to distinguish the missense and truncating patient populations... primarily because it's easier to lump later than split. @sbello, @lschriml thoughts?
@sbello & @lschriml, this is a bit complicated so I welcome your thoughts on how best to proceed. So here's what I'm thinking:
The primary upside to lumping missense and truncation into a single entry is that it makes it easier to attach models to disease where the phenotype may be the same but the mutation type may differ. It is really helpful to have a less specific term or parent term that is more specific than 'syndrome'. Points 1 and 2 make sense to me.
Just noting additional sources/references that treat 'Timothy syndrome' and LQT8 as equivalent:
These don't alter my plan but they will complicate mapping to these resources. The phenotypic separation & classification for Timothy syndrome appears to be a mess right now. OMIM is still most likely to be correct.
I understand your comment about lumping the mutants for NEDHLSS. Since OMIM has included both mutation types, I will also include them both. We can always split them later if the distinction becomes more definitive.
In OMIM CACNA1C is associated with 4 disease but only 2 of these are in DO. Please add new terms for:
https://www.omim.org/entry/618447 Long QT syndrome 8 child of DOID:2843 definition: A long QT syndrome that has_material_basis_in dominant inheritance of mutation in the CACNA1C gene on chromosome 12p13.33. ref: PMID:10220144
Possibly this is the same as Timothy syndrome. OMIM has separate records for these but Orphanet and GARD combines these in a single record (https://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=EN&Expert=65283 and https://rarediseases.info.nih.gov/diseases/9294/disease)
Note that the Long QT syndrome series is also missing other members, see https://www.omim.org/phenotypicSeries/PS192500?sort=phenotype for review
https://www.omim.org/entry/620029 Neurodevelopmental disorder with hypotonia, language delay, and skeletal defects with or without seizures child of DOID:0060307 definition: An autosomal dominant intellectual developmental disorder characterized by global developmental delay apparent from infancy, severe hypotonia, poor or absent speech, impaired intellectual development with behavioral abnormalities, and mild skeletal defects that has_material_basis_in heterozygous missense or truncating mutations in the CACNA1C gene on chromosome 12p13. ref: PMID:34163037